Latest Content

Diagnosed with Hodgkin lymphoma at 18, Steve Garraty shares how survivorship, gratitude and purpose emerged from life's hardest chapter.

14 years after a rare lymphoma diagnosis, Edward Miskie answers real questions on survivorship, caregiving and life after cancer treatment.

After a kidney lesion proved unlikely to be cancer, a survivor embraces self-care, friendship and new opportunities with renewed gratitude and joy.

FDA approves Trodelvy alone or with Keytruda for the first-line treatment of adults with unresectable locally advanced or metastatic triple-negative breast cancer.

Susan Yaguda, oncology nurse at Atrium Health Levine Cancer Institute, transforms cancer care by treating the whole person — mind, body, and spirit — one patient at a time.

FDA approves Ibrance with trastuzumab and endocrine therapy for maintenance treatment of HR-positive, HER2-positive metastatic breast cancer.

A four-time cancer survivor shares how the Mariana Trench mirrors the journey through cancer, resilience, hope, and survival.

Nurse Navigator Nicola Stewart helped a Vietnamese-speaking patient with metastatic colon cancer overcome language, financial and care barriers.

FDA grants full approval to TECELRA and expands its use to eligible patients ages 12 and older with advanced synovial sarcoma after chemotherapy.

EHA 2026 brought new data on myeloma, leukemia and lymphoma. Here's what patients and caregivers should know about five key studies.

Six years after remission, a survivor reflects on scan anxiety, recurrence fears, and the uncertainty of living with chronic cancer.

Oncology physical therapist Dr. Leslie Waltke, speaks with CURE , on identifying high-risk patients, overcoming the instinct to rest, and breaking down barriers to rehab access during cancer treatment.

“For nearly 11 years, my sister measured her cancer fight in holidays—wondering if she'd see spring again, or one more Christmas.”